8,640
Total Claims
$1.1M
Drug Cost
719
Beneficiaries
$1,543
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-94%
Opioid rate vs peers
0.1% vs 2.2% avg
+9%
Cost per patient vs peers
$1,543 vs $1,411 avg
+22%
Brand preference vs peers
12.9% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$39
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 1,107 claims · $944K
Generic: 7,457 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 71 | $126K |
| Empagliflozin | 89 | $120K |
| Semaglutide | 43 | $89K |
| Linagliptin | 56 | $70K |
| Dapagliflozin Propanediol | 50 | $68K |
| Sitagliptin Phosphate | 43 | $50K |
| Apixaban | 55 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $30K |
| Denosumab | 17 | $29K |
| Rivaroxaban | 12 | $22K |
| Umeclidinium Brm/Vilanterol Tr | 18 | $15K |
| Icosapent Ethyl | 17 | $15K |
| Insulin Degludec | 11 | $15K |
| Fluticasone/Vilanterol | 22 | $14K |
| Linaclotide | 14 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
52%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data